AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 33 filers reported holding AURA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,672,711 | -32.7% | 743,892 | -7.4% | 0.57% | -40.6% |
| Q2 2023 | $9,921,064 | +26.8% | 803,325 | -4.8% | 0.96% | +59.8% |
| Q1 2023 | $7,827,179 | -6.7% | 843,446 | +5.6% | 0.60% | +10.3% |
| Q4 2022 | $8,386,886 | +20.6% | 798,751 | +108.1% | 0.54% | +20.9% |
| Q3 2022 | $6,954,000 | +43.0% | 383,764 | +11.8% | 0.45% | +84.4% |
| Q2 2022 | $4,863,000 | -26.8% | 343,215 | +13.7% | 0.24% | -17.0% |
| Q1 2022 | $6,644,000 | +294.8% | 301,990 | +204.6% | 0.29% | +398.3% |
| Q4 2021 | $1,683,000 | – | 99,146 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $27,267,831 | 8.71% |
| Decheng Capital Management III (Cayman), LLC | 1,163,123 | $18,243,928 | 6.09% |
| Regency Capital Management Inc.\DE | 526,978 | $4,726,993 | 4.02% |
| Matrix Capital Management Company, LP | 5,362,870 | $48,104,944 | 0.58% |
| Nantahala Capital Management | 743,892 | $6,672,711 | 0.57% |
| Eventide Asset Management | 3,024,905 | $27,133,398 | 0.49% |
| Rock Springs Capital Management LP | 722,896 | $6,484,377 | 0.17% |
| LEVIN CAPITAL STRATEGIES, L.P. | 81,095 | $727,422 | 0.09% |
| Long Focus Capital Management, LLC | 195,175 | $1,750,720 | 0.06% |
| Values First Advisors, Inc. | 10,401 | $93,299 | 0.06% |